AVCO Avalon GloboCare Corp. Stock Quote

AVCO [NASD]

Healthcare | Medical Care Facilities | USA

Index	-	P/E	-	EPS (ttm)	-0.10	Insider Own	63.57%	Shs Outstand	88.50M	Perf Week	6.14%
Market Cap	42.30M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	32.74M	Perf Month	-17.51%
Income	-8.80M	PEG	-	EPS next Q	-	Inst Own	1.00%	Short Float	1.52%	Perf Quarter	-33.35%
Sales	1.40M	P/S	30.21	EPS this Y	32.90%	Inst Trans	-17.56%	Short Ratio	6.98	Perf Half Y	-47.52%
Book/sh	0.01	P/B	46.70	EPS next Y	-	ROA	-86.50%	Target Price	-	Perf Year	-52.99%
Cash/sh	0.01	P/C	84.60	EPS next 5Y	-	ROE	-372.30%	52W Range	0.40 - 1.19	Perf YTD	-43.05%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-140.20%	52W High	-60.76%	Beta	0.91
Dividend %	-	Quick Ratio	0.20	Sales past 5Y	17.70%	Gross Margin	30.10%	52W Low	16.58%	ATR	0.05
Employees	5	Current Ratio	0.20	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	46.08	Volatility	8.48% 9.26%
Optionable	No	Debt/Eq	2.46	EPS Q/Q	17.50%	Profit Margin	-	Rel Volume	0.38	Prev Close	0.47
Shortable	Yes	LT Debt/Eq	2.46	Earnings	-	Payout	-	Avg Volume	71.45K	Price	0.47
Recom	-	SMA20	-5.30%	SMA50	-10.27%	SMA200	-39.31%	Volume	27,116	Change	-1.68%

Jun-30-22 09:00AM	Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer GlobeNewswire +6.74%
Jun-01-22 06:26AM	Even after rising 13% this past week, Avalon GloboCare (NASDAQ:AVCO) shareholders are still down 73% over the past three years Simply Wall St.
May-25-22 09:00AM	Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference GlobeNewswire
May-18-22 09:00AM	Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy GlobeNewswire -6.25%
May-10-22 11:10AM	10 Penny Stocks to Buy in May Insider Monkey -7.80%
Apr-27-22 09:00AM	Avalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications GlobeNewswire
Feb-14-22 11:57AM	Avalon GloboCare Adds CAR-NK Cell Therapies To Expand Cellular Immuno-Oncology Platform Benzinga
09:00AM	Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies GlobeNewswire
Jan-04-22 09:00AM	Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs GlobeNewswire
Dec-22-21 09:00AM	Avalon GloboCares Chairman Converts Debt into Common Stock at 45% Premium to Market GlobeNewswire
Dec-09-21 09:00AM	Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development GlobeNewswire
Dec-06-21 04:18AM	Shareholders in Avalon GloboCare (NASDAQ:AVCO) are in the red if they invested three years ago Simply Wall St.
Nov-15-21 05:20PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GTS, BRBS, IRT, AVCO, LMRK; Shareholders are Encouraged to Contact the Firm PR Newswire
Nov-11-21 11:25PM	AVALON GLOBOCARE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Avalon GloboCare Corp. - AVCO PR Newswire
Oct-14-21 09:20AM	Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy GlobeNewswire
Oct-07-21 09:01AM	Avalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients Benzinga
09:00AM	Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases GlobeNewswire
Sep-30-21 10:52AM	Avalon GloboCare Aims to Revolutionize Cell Therapy Market with a Faster, Safer CAR-T Treatment Benzinga
Sep-23-21 09:00AM	Avalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30th GlobeNewswire
Sep-13-21 09:30AM	Sysorex Elects Nasdaq-Listed Company CEO William Stilley to Board of Directors GlobeNewswire
Sep-09-21 04:32AM	INVESTIGATION: Halper Sadeh LLP Investigates INOV, SAFM, LMRK, AVCO, TRIL, XENT; Shareholders are Encouraged to Contact the Firm PR Newswire
Sep-08-21 12:11PM	AVALON GLOBOCARE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Avalon GloboCare Corp. - AVCO Business Wire
Aug-04-21 09:00AM	UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare GlobeNewswire -5.51%
Jul-20-21 01:30PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KRG, ALTA, AVCO, ICBK; Shareholders are Encouraged to Contact the Firm ACCESSWIRE
Jul-19-21 10:30AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Avalon GloboCare Corp. Merger GlobeNewswire
Jul-18-21 09:00AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CAI, SYKE, TGRF, AVCO, LDL; Shareholders are Encouraged to Contact the Firm PR Newswire
Jul-16-21 09:00PM	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Avalon GloboCare Corp. - AVCO PR Newswire
Jul-01-21 09:00AM	Avalon GloboCare Announces its Planned Acquisition Target, SenlangBio, has Initiated First-In-Human Clinical Trial in Recurrent Brain Cancer GlobeNewswire
Jun-28-21 09:04AM	Avalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio GlobeNewswire
Jun-21-21 09:00AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm ACCESSWIRE -5.90%
Jun-18-21 07:32PM	Lifshitz Law Firm, P.C. Announces Investigation of AVCO, ICON, KIN, and KNL ACCESSWIRE -6.67%
Jun-15-21 11:28PM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates FBNC, AVCO, XEC, CLDR, SBBP; Shareholders are Encouraged to Contact the Firm PR Newswire
03:54PM	Lifshitz Law Firm, P.C. Announces Investigation of ALTA, AVCO, CORE, and EBSB GlobeNewswire
Jun-14-21 05:47PM	Avalon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Avalon GloboCare Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm AVCO Business Wire
12:49PM	Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights Benzinga
09:00AM	Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction GlobeNewswire
Jun-11-21 09:00AM	Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021 GlobeNewswire
Jun-09-21 01:47AM	If You Had Bought Avalon GloboCare's (NASDAQ:AVCO) Shares Three Years Ago You Would Be Down 58% Simply Wall St.
Jun-08-21 09:00AM	Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell Summit GlobeNewswire
Mar-29-21 09:25AM	Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR Platform GlobeNewswire
Mar-22-21 09:00AM	Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer Metastasis GlobeNewswire
Feb-09-21 10:30AM	Siyata Mobile Appoints Peter Goldstein as Chairman and Adds Seasoned Public Company Executive Luisa Ingargiola to Board of Directors GlobeNewswire
Jan-23-21 01:24AM	What Kind Of Shareholders Hold The Majority In Avalon GloboCare Corp.'s (NASDAQ:AVCO) Shares? Simply Wall St.
Dec-30-20 09:00AM	Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines and Cellular Therapeutics GlobeNewswire
Nov-16-20 11:37PM	Avalon GloboCare's(NASDAQ:AVCO) Share Price Is Down 59% Over The Past Three Years. Simply Wall St.
Oct-22-20 08:30AM	Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices GlobeNewswire
08:30AM	Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices ACCESSWIRE
Sep-03-20 11:11AM	Avalon GloboCare CEO to Participate in Virtual Panel: New Approaches to COVID-19: Hidden Breakthroughs, on Thursday, September 10th GlobeNewswire
09:00AM	Avalon GloboCare Announces Mesenchymal Stromal Cell Therapeutic Platform for COVID-19 and Acute Graft Versus Host Disease (aGVHD) GlobeNewswire
Sep-01-20 10:24AM	Have Insiders Been Buying Avalon GloboCare Corp. (NASDAQ:AVCO) Shares? Simply Wall St. -7.04%
Aug-19-20 11:03AM	Why Avalon Globocare's Stock Is Trading Higher Today Benzinga +9.38%
09:00AM	Avalon GloboCare Announces Commercialization and Distribution Agreement with Cellex for COVID-19 Antibody Rapid Test Kit GlobeNewswire
Aug-12-20 09:00AM	Avalon GloboCare Expands AVA-Trap Program to Treat COVID-19 and CAR-T Related Cytokine Storms GlobeNewswire
Jul-13-20 09:00AM	Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19 GlobeNewswire
Jul-03-20 02:37PM	Here's What Avalon GloboCare Corp.'s (NASDAQ:AVCO) Shareholder Ownership Structure Looks Like Simply Wall St.
Jun-29-20 09:30AM	Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001 GlobeNewswire
Jun-25-20 09:00AM	Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate GlobeNewswire +10.34%
Jun-16-20 09:00AM	Eminent Member of the Austrian Academy of Sciences, Professor Uwe B. Sleytr, Joins Avalon GloboCare's Scientific and Clinical Advisory Board GlobeNewswire
Jun-11-20 09:00AM	Avalon GloboCare Announces Three-Way Material Transfer Agreement with Weill Cornell Medicine and Arbele Limited for Development of Next Generation Cellular Immunotherapy FLASH-CAR Technology GlobeNewswire -7.06%
Jun-08-20 09:00AM	Avalon GloboCare Announces Diagnostic Platform for Point-of-Care Rapid Detection of COVID-19 (SARS-CoV-2) and Its Clinically Relevant Mutation Strains GlobeNewswire +7.23%
May-08-20 09:00AM	Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR Technology for Blood Cancers GlobeNewswire +13.26%
Apr-28-20 09:00AM	Avalon GloboCare Partners with HydroPeptide, a Leader in Epigenetics Skin Care, to Accelerate Regenerative ACTEX Product Development and Commercialization GlobeNewswire
Apr-20-20 08:30AM	Avalon GloboCare Achieves Major Milestones Advancing Immunotherapeutic Program towards Combatting Cytokine Storm Associated with COVID-19 Lung Damage and Mortality GlobeNewswire +6.47%
Feb-24-20 08:30AM	Avalon GloboCare to Present at the 32nd Annual ROTH Conference on March 16, 2020 GlobeNewswire -5.56%
Feb-04-20 09:00AM	Avalon GloboCare CEO David Jin, M.D., Ph.D. to Co-Chair the Cellular Therapy in the Asia Pacific Region Session at the Annual Meetings of the Transplantation and Cellular Therapy (TCT) -- ASTCT and CIBMTR Tandem Meeting 2020 GlobeNewswire -7.02%
Jan-14-20 06:38AM	Are Insiders Buying Avalon GloboCare Corp. (NASDAQ:AVCO) Stock? Simply Wall St.
Jan-06-20 08:30AM	Avalon GloboCare to Present at Biotech Showcase 2020 GlobeNewswire
Dec-20-19 08:30AM	Avalon GloboCare Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines GlobeNewswire
Nov-20-19 08:30AM	Avalon GloboCare to Present at the 12th Annual LD Micro Main Event on December 10th ACCESSWIRE
Nov-15-19 05:26AM	Can We See Significant Insider Ownership On The Avalon GloboCare Corp. (NASDAQ:AVCO) Share Register? Simply Wall St.
Oct-21-19 08:00AM	Avalon GloboCare Enters Agreement to Repurchase 100% of Outstanding Warrants GlobeNewswire +5.03%
Sep-19-19 08:00AM	Avalon GloboCare Announces Initiation of First-in-Human Clinical Trial of its CAR-T Candidate, AVA-001, for Treatment of B-Cell Malignancies GlobeNewswire
Sep-17-19 03:04PM	Former Dublin couple accused of stealing trade secrets from Nationwide Children's American City Business Journals
Sep-03-19 08:00AM	Avalon GloboCare Announces $20 Million Credit Facility Provided by Company Chairman GlobeNewswire
Jul-22-19 09:00PM	MULTIMEDIA UPDATE: Avalon GloboCare and GE Healthcare Announce Strategic Partnership to Accelerate Standardized Automation and Bio-production for Cellular Medicines GlobeNewswire
04:30PM	Avalon GloboCare and GE Healthcare Announce Strategic Partnership to Accelerate Standardized Automation and Bio-production for Cellular Medicines GlobeNewswire
Jul-15-19 08:00AM	Avalon GloboCare Provides Updates on its Lead Clinical Programs in CAR-T Therapy and Exosome-Based Regenerative Therapeutics GlobeNewswire
Jun-26-19 08:30AM	Avalon GloboCare Appoints Dr. Yen-Michael Sheng Hsu, Founding Director of cGMP Cellular Therapy Facility at Weill Cornell Medicine, to its Scientific and Clinical Advisory Board GlobeNewswire
Jun-18-19 08:00AM	Avalon GloboCare Expected to Join the Russell 3000® Index PR Newswire
Jun-13-19 08:00AM	Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference PR Newswire
Jun-10-19 08:00AM	Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization PR Newswire
May-21-19 09:00AM	Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy GlobeNewswire
Apr-25-19 08:58AM	Avalon GloboCare Announces $6 Million Registered Direct Offering with Institutional Investors ACCESSWIRE
Apr-24-19 08:00AM	Eminent M.I.T. Institute Professor, Robert S. Langer, Sc.D., Joins Avalon GloboCare's Scientific and Clinical Advisory Board ACCESSWIRE
Apr-17-19 08:00AM	Avalon GloboCare to Host The 3rd Annual International Scientific Forum on Exosome Research and Application (ISFERA) in Beijing on July 19, 2019 ACCESSWIRE
Apr-08-19 08:35AM	Avalon GloboCare Appoints Finance Veteran Yue ''Charles'' Li to the Board of Directors ACCESSWIRE
Mar-06-19 08:00AM	Avalon GloboCare to Present at the 31st Annual ROTH Conference on March 17-19, 2019 ACCESSWIRE
Feb-26-19 08:00AM	Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy GlobeNewswire
Feb-11-19 08:30AM	Avalon GloboCare Announces Breakthrough in Identifying Human Angiogenic Exosomes/Extracellular Vesicles (EV) Derived from Endothelial Cells GlobeNewswire
Feb-04-19 08:15AM	Avalon GloboCare CEO David Jin, M.D., Ph.D. to Co-Chair the Status of Cellular Therapy in the Asia Pacific Rim Session at the Annual Meetings of the Transplantation and Cellular Therapy (TCT) -- ASBMT and CIBMTR Tandem Meeting 2019 GlobeNewswire
Jan-29-19 10:29AM	Avalon GloboCare Stock Is an Expensive Mystery InvestorPlace
Jan-28-19 08:45AM	Avalon GloboCare's stock rockets to pace premarket gainers after positive study results MarketWatch
08:00AM	Avalon GloboCare and its Subsidiary Genexosome Technologies Announce Discovery and Development of Worlds First Saliva-Based Exosomal Biomarker miR-185 as Dual Diagnostic and Therapeutic Target for Oral Cancer GlobeNewswire
Jan-23-19 01:44PM	Mystery Surrounds the Sudden Activity in AVCO Stock InvestorPlace
Jan-16-19 04:00PM	OTC Markets Group Announces Quarterly Index Performance and Rebalancing PR Newswire
Jan-15-19 08:00AM	Avalon GloboCare CEO David Jin, M.D., Ph.D. to Chair and Speak at the Plenary Session of the 14th Annual World Stem Cell Summit GlobeNewswire
Jan-03-19 09:00AM	Avalon GloboCare Establishes Joint Venture with Arbele Limited to Co-develop Next-Generation Multi-Targeted CAR-T Cellular Immunotherapy GlobeNewswire
Dec-26-18 10:43AM	Avalon GloboCare Corp. (NASDAQ:AVCO) Insiders Increased Their Holdings Simply Wall St.
Dec-19-18 08:00AM	Avalon GloboCare to Ring the Nasdaq Stock Market Closing Bell on January 7, 2019 at 4:00 PM Eastern GlobeNewswire
Nov-13-18 09:05AM	Avalon GloboCare Provides Third Quarter 2018 Business Update; Reports 30% Increase in Revenues GlobeNewswire

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience